- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Kathy Oubre on Challenges, Solutions to Addressing Clinical Trial Participation
The clinicians and nurses at Pontchartrain Cancer Center address the education behind the clinical trials, which helps patients understand that they can have access to cutting edge therapy that they would not otherwise have access to, said Kathy W. Oubre, MS, chief operating officer at Pontchartrain Cancer Center. Kathy Oubre is additionally scheduled to speak at the Community Oncology Alliance Virtual Meeting, which runs from April 23-24, 2020.
"Our clinicians and our nurses address the education behind the clinical trials, the ability to, in a lot of cases, have access to cutting edge therapy that they would not otherwise have access to," said Kathy W. Oubre, MS, chief operating officer at Pontchartrain Cancer Center. Kathy Oubre is additionally scheduled to speak at the Community Oncology Alliance Virtual Meeting, which runs from April 23-24, 2020 and can be registered for here.
Transcript
Pontchartrain Cancer Center is located in southeastern Louisiana; what challenges do you face when providing care to patients in this area?
So, you have to first get past the stigma of the patient feeling like a test subject. I think that was very common 10 or 20 years ago. I think clinical trials got a bad reputation from that. We primarily address that through education. Our clinicians and our nurses just address the education behind the clinical trials, the ability to, in a lot of cases, have access to cutting edge therapy that they would not otherwise have access to. Educating them about all of the advances in science and how they might be able to have that hand in changing therapy for themselves and other people coming after them.
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Advancing Integrated Care for Comorbid Schizophrenia and Substance Use Disorder
February 11th 2025Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, outlines the progression of treatment approaches for comorbid schizophrenia and substance use disorder.
Read More
